Pediatric HIV type 1 vaccine trial acceptability among mothers in Kenya

AIDS Research and Human Retroviruses

Volumn 22, Issue 6, 2006, Pages 491-495

  Farquhar, Carey ^a,c   John Stewart, Grace C ^a   John, Francis N ^b   Kabura, Marjory N ^b   Kiarie, James N ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c Box 359909 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; FALSE POSITIVE RESULT; FEAR; FEMALE; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFECTION RISK; KENYA; MAJOR CLINICAL STUDY; MOTHER; MULTIVARIATE ANALYSIS; PATIENT ATTITUDE; PATIENT PARTICIPATION; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; UNIVARIATE ANALYSIS; UNSPECIFIED SIDE EFFECT; VACCINATION; VERTICAL TRANSMISSION;

ADULT; AIDS VACCINES; CHILD; CLINICAL TRIALS; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HIV-1; HUMANS; KENYA; MALE; MOTHERS; PATIENT ACCEPTANCE OF HEALTH CARE; PEDIATRICS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REFUSAL TO PARTICIPATE; VACCINATION;

EID: 33745698600     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.491     Document Type: Article

References (24)

1. John-Stewart G, Mbori-Ngacha D, Ekpini R, et al.: Breast-feeding and transmission of HIV-1. J Acquir Immune Defic Syndr 2004;35(2):196-202.
2. Safrit JT: HIV vaccines in infants and children: Past trials, present plans and future perspectives. Curr Mol Med 2003;3(3):303-312.
3. Safrit JT, Ruprecht R, Ferrantelli F, et al.: Immunoprophylaxis to prevent mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr 2004;35(2):169-177.
4. Cunningham CK, Wara DW, Rang M, et al.: Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women. Clin Infect Dis 2001;32(5):801-807.
5. Johnson DC, McFarland EJ, Muresan P, et al.: Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women. J Infect Dis 2005;192(12):2129-2133.
6. Freeman VA and Freed GL: Parental knowledge, attitudes, and demand regarding a vaccine to prevent varicella. Am J Prevent Med 1999;17(2):153-155.
7. Prislin R, Dyer JA, Blakely CH, and Johnson CD: Immunization status and sociodemographic characteristics: The mediating role of beliefs, attitudes, and perceived control. Am J Public Health 1998;88(12):1821-1826.
8. Wischnack LL, Jacobson RM, Poland GA, Jacobsen SJ, Harrison JM, and Murtaugh PA. The surprisingly high acceptability of low-efficacy vaccines for otitis media: A survey of parents using hypothetical scenarios. Pediatrics 1995;95(3):350-354.
9. Harrington PM, Woodman C, and Shannon WF: Vaccine, yes; injection, no: Maternal responses to the introduction of Haemophilus influenzae type b (Hib) vaccine. Br J Gen Pract 1999;49 (448):901-902.
10. Zimet GD, Mays RM, Winston Y, Kee R, Dickes J, and Su L: Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med 2000;9(1):47-50.
11. Zimet GD, Kee R, Winston Y, Perkins SM, and Maharry K: Acceptance of hepatitis B vaccination among adult patients with sexually transmitted diseases. Sex Transm Dis 2001;28(11):678-680.
12. Zimet GD, Fortenberry JD, Fife KH, Tyring SK, Herne K, and Douglas JM: Acceptability of genital herpes immunization. The role of health beliefs and health behaviors. Sex Transm Dis 1997;24(10):555-560.
13. Liau A, Zimet GD, and Fortenberry JD: Attitudes about human immunodeficiency virus immunization: The influence of health beliefs and vaccine characteristics. Sex Transm Dis 1998;25(2):76-81.
14. Gagnon MP and Godin G: Young adults and HIV vaccine: Determinants of the intention of getting immunized. Can J Public Health 2000;91(6):432-434.
15. Baeten JM, Richardson BA, Martin HL, Jr, et al.: Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: Implications for HIV-1 vaccine efficacy trials. J Acquir Immune Defic Syndr 2000;24(5):458-464.
16. Hom DL, Johnson JL, Mugyenyi P, et al.: HIV-1 risk and vaccine acceptability in the Ugandan military. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15(5):375-380.
17. Mays RM and Zimet GD: Recommending STI vaccination to parents of adolescents: The attitudes of nurse practitioners. Sex Transm Dis 2004;31(7):428-432.
18. Mays RM, Sturm LA, and Zimet GD: Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med 2004;58(7):1405-1413.
19. McClure CA, Gray G, Rybczyk GK, and Wright PF: Challenges to conducting HIV preventative vaccine trials with adolescents. J Acquir Immune Defic Syndr 2004;36(2):726-733.
20. Zimet GD, Mays RM, Sturm LA, Ravert AA, Perkins SM, and Juliar BE: Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med 2005;159(2):132-137.
21. Lazcano-Ponce E, Rivera L, Arillo-Santillan E, Salmeron J, Hernandez-Avila M, and Munoz N: Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res 2001;32(3):243-247.
22. Hinds A and Cameron JC: Acceptability of universal hepatitis B vaccination among school pupils and parents. Commun Dis Public Health 2004;7(4):278-282.
23. Short MB, Rupp R, Stanberry LR, and Rosenthal SL: Parental acceptance of adolescent vaccines within school-based health centres. Herpes 2005;12(1):23-27.
24. Farquhar C, Kiarie JN, Richardson BA, et al.: Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission. J Acquir Immune Defic Syndr 2004;37(5):1620-1626.